List of bibliographic references indexed by azithromycin
Number of relevant bibliographic references: 183.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000001 (2021) |
Daniel G. Dauner ; Kim Nichols Dauner | Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic. |
000004 (2021) |
Stéphane Honoré [France] ; Philippe Gautret [France] | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients. |
000005 (2021) |
Elisa Baranski Lamback [Brésil] ; Monica Amorim De Oliveira [Brésil] ; Andrea Ferreira Haddad [Brésil] ; André Filipe Marcondes Vieira [Brésil] ; Armando Leão Ferreira Neto [Brésil] ; Taciana Da Silva Maia [Brésil] ; Juliana De Rezende Chrisman [Brésil] ; Pedro Pimenta De Mello Spineti [Brésil] ; Marco Antonio De Mattos [Brésil] ; Eduardo Costa [Brésil] | Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19. |
000011 (2021) |
Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. |
000014 (2021) |
Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne] | Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. |
000018 (2021) |
Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne] | [Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients]. |
000042 (2021) |
Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne] | Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients. |
000044 (2021) |
Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis] | Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. |
000055 (2021) |
Tuan V. Nguyen [Australie] | Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. |
000057 (2021) |
Nobuaki Mori [Japon] ; Mitsuya Katayama [Japon] ; Shigenari Nukaga [Japon] | Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. |
000073 (2021) |
Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France] | Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients. |
000085 (2021) |
Nijad Bakhshaliyev [Turquie] ; Ramazan Özdemir [Turquie] | The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course. |
000097 (2021) |
Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis] | The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin. |
000138 (2021) |
Katharina Habler [Allemagne] ; Mathias Brügel [Allemagne] ; Daniel Teupser [Allemagne] ; Uwe Liebchen [Allemagne] ; Christina Scharf [Allemagne] ; Ulf Schönermarck [Allemagne] ; Michael Vogeser [Allemagne] ; Michael Paal [Allemagne] | Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum. |
000149 (2021) |
Amir Sarayani [États-Unis] ; Brian Cicali [États-Unis] ; Carl H. Henriksen [États-Unis] ; Joshua D. Brown [États-Unis] | Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. |
000150 (2021) |
Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. |
000193 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. |
000194 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Stéphane Honoré [France] ; Yanis Roussel [France] ; Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. |
000218 (2021) |
Marcelo Rodrigues Dos Santos [Brésil] | Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. |
000224 (2021) |
Matthieu Million [France] ; Yanis Roussel [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. |
000225 (2021) |
Alexis Lacout [France] ; Pierre Yves Marcy [France] ; Christian Perronne [France] | Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "azithromycin"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "azithromycin" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= azithromycin
}}
| This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 | |